Skip to content

Observational study of early sacroiliac joint disorders after adult spinal deformity

Observational study of early sacroiliac joint disorders after adult spinal deformity - Observational study of early sacroiliac joint disorders after adult spinal deformity

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000045489
Enrollment
98
Registered
2021-09-15
Start date
2021-07-23
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

adult spinal deformity

Interventions

None listed

Sponsors

Wakayama Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Between January 2019 and December 2020, all consecutive patients who have (1) symptomatic ASD and (2) receive long corrective fusion from the thorax to the pelvis using S2AI screws are enrolled in the study.

Exclusion criteria

Exclusion criteria: The exclusion criteria are as follows: (1) history of spine surgery, (2) bedridden status due to pre-existing problems, (3) current severe infection, or concurrent acute fracture.

Design outcomes

Primary

MeasureTime frame
All patients with ASD, treated with long spinal fusion using S2AI screws, are prospectively investigated for SIJP postoperatively, and the effect of ultrasound-guided sacroiliac joint block evaluated. Additionally, the relationship between the symptomatic side of the SIJP and the surgical procedure; the preoperative and postoperative whole spine sagittal and coronal alignment, lumbar pelvis sagittal plane alignment and pelvic incidence-lumbar lordosis are retrospectively compared between the groups with and without SIJP.

Countries

Japan

Contacts

Public ContactShizumasa Murata

Wakayama Medical University Department of Orthopedic Surgery

shizuman.612@gmail.com0734410645

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026